Skip to main content
Tessa NewsLink
Paste a health news link, or browse
Latest checks

Several possible studies

Story checked

Unlocking drug discovery: The power of omics technologies (opens in a new tab)

news-medical.net · 2026-10-23

Short answerEvidenceSource

Short answer

Several possible studies

Study not confirmed.

Several potential source studies were identified, but no single match could be confirmed. The article's claims remain unverified.

19 candidate papersExplore the search results

These papers were considered as possible sources, but none could be confirmed as the study behind this story.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Multiple potential source studies identified.

Several studies match details in the article, but none could be confirmed as its source. The claims have not been assessed against a source study.

View article claims
3

Search result

Several studies could fit.

Several studies match details in the article, but none could be confirmed as its source. The claims have not been assessed against a source study.

The literature search

19 candidate papers

Studies identified during the search

These papers appeared in the search for the story’s source. None was confirmed as a direct match. Inclusion here does not mean a paper supports or contradicts the story, or that its full text was reviewed.

Show 15 more search results
Then inspect each claim

Evidence layer

Claim by claim

The article's claims are listed below. Without a confirmed source study, they have not been assessed as supported or unsupported.

Claim 1 of 6Not checkedDr. Shi-Qi An says integrating different omics approaches can uncover complex biological mechanisms, improve experimental design, and support drug discovery.View evidenceHide evidence

Not checked

No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.

Claim 2 of 6Not checkedThe article says multi-omics studies are usually still limited to combining two or three data types, and that it is relatively rare to see studies integrating genomics, epigenomics, transcriptomics, proteomics, and metabolomics together.View evidenceHide evidence

As statedtwo or perhaps three types of data; relatively rare

Not checked

No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.

Claim 3 of 6Not checkedDr. An says genomic or transcriptomic changes do not always translate directly into the same protein or metabolite changes, and that those discrepancies can be informative.View evidenceHide evidence

Not checked

No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.

Claim 4 of 6Not checkedShe says combining genomic information with single-cell transcriptomics can help identify specific cell populations associated with treatment resistance in cancer research.View evidenceHide evidence

Not checked

No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.

Claim 5 of 6Not checkedThe article says single-cell technologies are especially powerful for heterogeneous populations, while bulk approaches can miss small cell populations that behave differently from the rest of a tissue or tumor.View evidenceHide evidence

Not checked

No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.

Claim 6 of 6Not checkedDr. An says bioinformatics should be considered part of experimental design and that not every association in omics data represents a direct biological mechanism.View evidenceHide evidence

Not checked

No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.

Finally, the search trail

Method layer

Study not confirmed.

The search results are available for you to inspect. Without a confirmed source study, they cannot establish whether the story’s claims are supported or contradicted.

Search results

Candidate papers, not confirmed sources.

PubMed, Europe PMC, Crossref · 15 candidate papers

Candidate

A multi-omics study integrating single-cell transcriptomics, spatial transcriptomics, and mendelian randomization unveil the implication of TRDMT1 expression in T cells on the immunotherapeutic response and prognosis in breast cancer.

Functional & Integrative Genomics · 2026 · PubMed, Europe PMC

Tessa (opens in a new tab)Source (opens in a new tab)

Explore all search results